Slide 1: Business Results, First Three Months of the Fiscal Year Ending March 31, 2027
Business Results First Three Months of the Fiscal Year Ending March 31, 2027 Sysmex Corporation August 7, 2026
Slide 2: Disclaimer
Disclaimer ・This material contains forward-looking statements about the Sysmex Group. These forward-looking statements are based on the current judgments and assumptions of the Sysmex Group in light of the information currently available to it. Uncertainties inherent in such judgments and assumption
Slide 3: Index
Index 1. Executive Summary 2. Business Results, First Three Months of the Fiscal Year Ending March 31, 2027 3. Strategic Themes under the Mid-Term Management Plan 4. Financial Forecast for the Fiscal Year Ending March 31, 2027 (Appendix) 3
Slide 4: 1. Executive Summary
1. Executive Summary
Slide 5: Executive Summary (First Three Months)
Executive Summary (First Three Months of the Fiscal Year Ending March 31, 2027: Year on Year) Strong growth in the Americas and yen depreciation drove substantial increases in sales and profits. Net sales Operating profit Profit attributable to owners of the parent ¥130.6 billion +23.6% YoY ¥14.8 bi
Slide 6: Executive Summary (Revised First-Half and Full-Year Forecasts)
Executive Summary (Revised First-Half and Full-Year Forecasts for the Fiscal Year Ending March 31, 2027) We revised our first-half forecast upward in light of strong business progress in the Americas. For the second half, we have maintained our initial forecast. First-half forecast (revised) Net s
Slide 7: 2. Business Results, First Three Months
2. Business Results, First Three Months of the Fiscal Year Ending March 31, 2027
Slide 8: Financial Highlights (Year on Year)
Financial Highlights (Year on Year) (Billions of yen) 130.6 First three months of First three months of fiscal year ending March 31, fiscal year ended March 31, 2027 2026 YoY (Previous 111.9 (Billions of yen) period = 100%) 105.7 Results Ratio Results Ratio 95.3 86.0 16.7 Net sales 130.6 100% 105.7
Slide 9: Breakdown of Net Sales (By Business and Field)
Breakdown of Net Sales (By Business and Field) Sales by Business and Field First three months of fiscal YoY year ending March 31, 2027 (Previous period = 100%) (Billions of yen) (Billions of yen) Excluding Excluding FX Results Ratio Yen basis impact China and FX FX impacts impact Net sales 130.6 100
Slide 10: Breakdown of Net Sales (By Destination and Product Type)
Breakdown of Net Sales (By Destination and Product Type) Substantial increase in net sales, driven by growth in the Americas, EMEA, AP, and Japan, together with the positive impact of yen depreciation First three months of fiscal year ending March 31, 2027 YoY (Previous period = 100%) Major Reasons
Slide 11: Information by Destination (Americas)
Information by Destination (Americas) YoY First three First three (Previous period = 100%) Favorable business performance continued, centered on months of fiscal months of fiscal (Million USD) year ending year ended North America and Brazil. Sales increased substantially, March 31, 2027 March 31, 20
Slide 12: Information by Destination (EMEA)
Information by Destination (EMEA) First three First three YoY months of fiscal months of fiscal (Previous period = 100%) year ending year ended Double-digit growth in major countries drove solid expansion (Million EUR) March 31, 2027 March 31, 2026 Local currency Yen basis across key fields, includi
Slide 13: Information by Destination (China)
Information by Destination (China) First three First three YoY (Previous period = 100%) months of fiscal months of fiscal Sales declined due to the continuing impact of healthcare year ending year ended (Million CNY) March 31, 2027 March 31, 2026 Local currency Yen basis cost control policies that b
Slide 14: China: Current Situation and Outlook for the Future
China: Current Situation and Outlook for the Future Q1 results remained inline with initial forecast and we maintained our initial full-year forecast YoY Change in Sales (Previous period = 100%)(Conceptual) (pt) FY3/26 (Full Year): FY3/27 (Full Year): Q1 Results for the Fiscal Year Ending March 31,
Slide 15: Second Round of Public Consultation on the Standardization of Testing Prices
Second Round of Public Consultation on the Standardization of Testing Prices June 30 announcement Comment submission deadline of July 6 (first round closed at the endo of March) ・Additional public consultation on testing parameters and ・Approximately 50 proposed additions and revisions in total
Slide 16: Information by Destination (AP)
Information by Destination (AP) First three First three (Billions of yen) months of fiscal months of fiscal YoY(Previous In addition to strong growth in India, a recovery in Indonesia year ending year ended period = 100%) March 31, 2027 March 31, 2026 Yen basis contributed to higher sales. 114.2% Ne
Slide 17: Information by Destination (Japan)
Information by Destination (Japan) First three First three Sales of both instruments and reagents returned to (Billions of yen) months of fiscal months of fiscal YoY(Previous year ending year ended period = 100%) typical levels. The clinical chemistry business we acquired March 31, 2027 March 31, 20
Slide 18: Breakdown of Operating Profit (Year on Year)
Breakdown of Operating Profit (Year on Year) Operating profit Note: Figures and comments below exclude the impact of exchange rates. Increase in gross profit due to higher sales: +¥6.86 billion Absence of the prior- year inventory (Billions of yen) Absence of the prior-year impact of inventory r
Slide 19: 3. Strategic Themes under the Mid-Term Management Plan
3. Strategic Themes under the Mid-Term Management Plan
Slide 20: Progress on Strategic Themes
Progress on Strategic Themes Accelerate Expansion in the Hemostasis Expansion in Emerging Markets EMEA Field ■Sales (Q1) Emerging Markets (Asia, Central and South America, Middle East, Africa) Q1 results (local currency basis), YoY: +41% (Billions of yen) 19.1 • Activities built on the existing hema
Slide 21: Progress on Initiatives to Improve Profitability
Progress on Initiatives to Improve Profitability Value Chain Reform Improving Productivity through AI and Digital Technologies A High-productivity Improving Reagent Profitability Internal data corporate structure • A Company-wide project is underway to improve reagent costs • Leveraging globally accu
Slide 22: 4. Financial Forecast for the Fiscal Year Ending March 31, 2027
4. Financial Forecast for the Fiscal Year Ending March 31, 2027
Slide 23: Revised Financial Forecast (First Half)
Revised Financial Forecast for the Fiscal Year Ending March 31, 2027 (First Half) Green indicates changes from the previous forecast (announced in May 2026). Q1 of fiscal year ending Q2 of fiscal year ending Announced forecast for first six months of March 31, 2027 March 31, 2027 fiscal year ending
Slide 24: Revised Financial Forecast for the First Half
Revised Financial Forecast for the First Half of the Fiscal Year Ending March 31, 2027 Net Sales Operating Profit (Billions of yen) (Billions of yen) Improved Increase cost of in other sales operating ratio losses FX impact Other Government Regions 265.0 Increased subsidies in 2.28 △ 2.28 3.8 gross
Slide 25: Revised Financial Forecast (Full Year)
Revised Financial Forecast for the Fiscal Year Ending March 31, 2027 (Full Year) Green indicates changes from the previous forecast (announced in May 2026). (Billions of yen) 2H of fiscal year ending March 31, 2027 Full-year forecast for fiscal year ending March 31, 2027 (October–March) (April–March
Slide 26: Revised Forecast (Sales by Business, Field, and Destination)
Revised Forecast for the Fiscal Year ending March 31, 2027 (Sales by Business, Field, and Destination) ■Sales by business and field ■Sales by destination Green indicates changes from the previous forecast (announced in May 2026). Fiscal year (Billions Fiscal year YoY (Previous period = (Billions of
Slide 27: (Appendix)
(Appendix)
Slide 28: Sustainability Targets: Creating value for a healthy society
Sustainability Targets Results for the Fiscal Year Ended March 31, 2026 Creating value for a healthy society ・The items whose targets are displayed as “-” are monitoring items for which no targets are set. Results Targets Materiality KPI Fiscal year ended Fiscal year ended Fiscal year ending March 3
Slide 29: Sustainability Targets: Reducing environmental impacts
Sustainability Targets Results for the Fiscal Year Ended March 31, 2026 Reducing environmental impacts ・The items whose targets are displayed as “-” are monitoring items for which no targets are set. Results Targets Materiality KPI Fiscal year ended Fiscal year ended Fiscal year ending March 31, 202
Slide 30: Sustainability Targets: Strengthening governance
Sustainability Targets Results for the Fiscal Year Ended March 31, 2026 Strengthening governance ・The items whose targets are displayed as “-” are monitoring items for which no targets are set. Results Targets Materiality KPI Fiscal year ended Fiscal year ended Fiscal year ending March 31, 2025 Marc
Slide 31: Sustainability Targets: Maximizing human capital
Sustainability Targets Results for the Fiscal Year Ended March 31, 2026 Maximizing human capital ・The items whose targets are displayed as “-” are monitoring items for which no targets are set. Results Targets Materiality KPI Fiscal year ended Fiscal year ended Fiscal year ending March 31, 2025 Marc
Slide 32: Sustainability Targets: Maximizing human capital (continued)
Sustainability Targets Results for the Fiscal Year Ended March 31, 2026 Maximizing human capital ・The items whose targets are displayed as “-” are monitoring items for which no targets are set. Results Targets Materiality KPI Fiscal year ended Fiscal year ended Fiscal year ending March 31, 2025 Marc
Slide 33: Together for a better healthcare journey
Together for a better healthcare journey